Showing results (231-240 of 5,334) with videos related to
Sort By:
Pageof 534
Journal of Chemical Information and Modeling|September 22, 2025
A Scalable and Generalizable Method to Minimize Solvent Interference in Identification of Chemical Reaction Networks from Spectroscopic DataKuldeep Singh, Karthik Srinivasan, Ziting Sun, et al.Congenital Heart Disease|April 2, 2008
Pathologic aneurysmal dilation of the ascending aorta and dilation of the main pulmonary artery in patients with Kabuki syndrome: valve-sparing aortic root replacementUmesh Dyamenahalli, Boban Abraham, Eudice Fontenot, et al.BMJ Open|January 14, 2025
Cross-sectional evaluation of medical reversals among National Institute of Health guideline practices implemented during the COVID-19 pandemic: how often did experts err in a time of crisis?Alec J Kacew, Alyson Haslam, Vinay Prasad, et al.Journal of Clinical Epidemiology|February 7, 2013
Observational studies often make clinical practice recommendations: an empirical evaluation of authors' attitudesVinay Prasad, Joel Jorgenson, John P A Ioannidis, et al.International Journal of Cancer|June 18, 2022
Eventual success rate and predictors of success for oncology drugs tested in phase I trialsAlyson Haslam, Timothée Olivier, Kerrington Powell, et al.JAMA Network Open|March 15, 2022
Cancer Drug Approvals That Displaced Existing Standard-of-Care Therapies, 2016-2021David J Benjamin, Alexander Xu, Mark P Lythgoe, et al.Journal of Cancer Policy|July 4, 2026
Science or spin? A descriptive analysis of how oncology trials are presented in three short form digital media outletsCallie Warren, Preetam Cholli, Alyson Haslam, et al.Oncotarget|July 24, 2015
Distinctive clinical characteristics of malignant mesothelioma in young patientsAnish Thomas, Yuanbin Chen, Tinghui Yu, et al.BMJ Oncology|January 31, 2025
Bedside implications of the use of surrogate endpoints in solid and haematological cancers: implications for our reliance on PFS, DFS, ORR, MRD and moreTimothée Olivier, Alyson Haslam, Dagney Ochoa, et al.JAMA Oncology|July 20, 2023
Cost of Drug Wastage From Dose Modification and Discontinuation of Oral Anticancer DrugsMichael Lam, Timothée Olivier, Alyson Haslam, et al.Pageof 534